Why Schizophrenia Treatment Falls Short: Stigma, Fear, and Delayed Care

Welcome back to another Psychiatric Times Peer Exchange series. In "Why Schizophrenia Treatment Falls Short: Stigma, Fear, and Delayed Care," moderator Richard Jackson, MD is joined by Ben Hunter, MD, FAPA, Tracy Hicks, DNP, MBA, APRN, FNP/PMHNP-BC, CARN-AP, FIAAN, FAANP, Spencer Simon, PA-C, and Gustavo Alva, MD, DFAPA to open the series by examining why effective care for schizophrenia remains so difficult to achieve.

Dr. Jackson opens by asking Dr. Alva why schizophrenia management continues to fall short, citing data showing only 26% of adults receive minimally adequate treatment. Dr. Alva attributes this gap to persistent fear surrounding a neuropsychiatric illness with a neurodegenerative course. He explains that a first psychotic break is often daunting for patients and families alike, creating an educational lag before anyone understands what is happening. Substance use, particularly marijuana and alcohol, frequently acts as a stressor that unmasks an underlying psychotic illness early in its course. Dr. Alva stresses that the first five years of treatment are critical, yet families often resist the diagnosis because schizophrenia currently has no cure and carries lifelong implications. He notes that more than a quarter of patients may not receive appropriate care partly because diagnosis itself remains uncertain in many cases. Clinicians, he argues, can do more to educate patients and reduce stigma, since effective treatments exist that can control symptoms when applied early and aggressively.

Dr. Jackson challenges this framing, arguing that responsibility extends well beyond patients and families to clinicians themselves. He questions whether the field's expectations for schizophrenia outcomes remain stuck in an outdated deinstitutionalization-era mindset, where simply keeping a patient out of the hospital counts as success. He argues that this standard, set fifty years ago, no longer reflects what modern treatment can achieve. Dr. Jackson suggests the panel needs to reset expectations toward genuine independence, family reintegration, and functional recovery rather than mere symptom containment. He proposes illustrating this shift through a detailed case presentation, setting up the discussion that follows and challenging the panel to define what real progress should look like for patients living with schizophrenia today.

The next episode in this series, "A Schizophrenia Case Study: Persistent Symptoms Beyond Hospitalization," brings the discussion to life through a detailed patient case that anchors the rest of the program.